NCT00478686View on ClinicalTrials.gov

Association of Dihydropyrimidine Dehydrogenase (DPYD) Variants With Toxicity Related to Capecitabine

CompletedOBSERVATIONAL
Enrollment

102

Participants

Timeline

Start Date

May 23, 2007

Primary Completion Date

May 2, 2017

Study Completion Date

May 2, 2017

Conditions
Breast Cancer
Interventions
PROCEDURE

Phlebotomy

5 to 7.5 milliliter (mL) Blood Sample

Trial Locations (1)

77030

University of Texas MD Anderson Cancer Center, Houston

Sponsors

Collaborators (1)

Myrexis Inc.
All Listed Sponsors
collaborator

Myrexis Inc.

INDUSTRY

lead

M.D. Anderson Cancer Center

OTHER

NCT00478686 - Association of Dihydropyrimidine Dehydrogenase (DPYD) Variants With Toxicity Related to Capecitabine | Biotech Hunter | Biotech Hunter